Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 35 | 2023 | 1209 | 6.770 |
Why?
|
Meningeal Neoplasms | 36 | 2023 | 1241 | 6.470 |
Why?
|
Brain Neoplasms | 51 | 2024 | 8863 | 3.040 |
Why?
|
Pituitary Neoplasms | 15 | 2021 | 1345 | 2.210 |
Why?
|
Skull Base Neoplasms | 6 | 2023 | 284 | 2.020 |
Why?
|
Radiosurgery | 6 | 2023 | 1329 | 1.580 |
Why?
|
Glioblastoma | 15 | 2024 | 3481 | 1.420 |
Why?
|
Craniopharyngioma | 4 | 2021 | 281 | 1.410 |
Why?
|
Glioma | 20 | 2024 | 3401 | 1.340 |
Why?
|
Neurosurgical Procedures | 19 | 2024 | 2002 | 1.080 |
Why?
|
Adenoma | 10 | 2021 | 2174 | 0.980 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 895 | 0.920 |
Why?
|
Neurosurgery | 3 | 2023 | 643 | 0.830 |
Why?
|
Neuroma, Acoustic | 4 | 2020 | 451 | 0.810 |
Why?
|
Gliosarcoma | 1 | 2021 | 114 | 0.780 |
Why?
|
Optic Nerve | 1 | 2024 | 554 | 0.750 |
Why?
|
Craniotomy | 6 | 2020 | 729 | 0.740 |
Why?
|
Pituitary Apoplexy | 2 | 2016 | 30 | 0.630 |
Why?
|
Clothing | 1 | 2018 | 92 | 0.610 |
Why?
|
DNA Copy Number Variations | 7 | 2017 | 1941 | 0.610 |
Why?
|
Magnetic Resonance Imaging | 31 | 2024 | 35421 | 0.600 |
Why?
|
Neoplasm Recurrence, Local | 19 | 2024 | 9239 | 0.600 |
Why?
|
Psychophysics | 1 | 2018 | 309 | 0.600 |
Why?
|
Patient Transfer | 1 | 2023 | 761 | 0.550 |
Why?
|
Elasticity | 1 | 2018 | 657 | 0.550 |
Why?
|
Acromegaly | 2 | 2021 | 346 | 0.540 |
Why?
|
Mutation | 30 | 2024 | 29786 | 0.540 |
Why?
|
Labyrinth Diseases | 1 | 2017 | 150 | 0.530 |
Why?
|
Semicircular Canals | 1 | 2017 | 198 | 0.520 |
Why?
|
Cranial Nerve Neoplasms | 3 | 2021 | 129 | 0.520 |
Why?
|
Humans | 150 | 2024 | 744343 | 0.500 |
Why?
|
Cerebellar Neoplasms | 3 | 2015 | 587 | 0.490 |
Why?
|
Chromosomes, Human | 1 | 2016 | 457 | 0.490 |
Why?
|
Motion Perception | 1 | 2018 | 408 | 0.480 |
Why?
|
Cerebral Veins | 1 | 2015 | 156 | 0.460 |
Why?
|
Tomography, Spiral Computed | 1 | 2015 | 280 | 0.450 |
Why?
|
Cerebral Angiography | 2 | 2018 | 1285 | 0.450 |
Why?
|
Histones | 1 | 2023 | 2599 | 0.440 |
Why?
|
Cerebral Arteries | 1 | 2015 | 494 | 0.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8428 | 0.400 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1622 | 0.400 |
Why?
|
Cranial Irradiation | 3 | 2023 | 401 | 0.400 |
Why?
|
Methionine | 1 | 2014 | 590 | 0.400 |
Why?
|
Monitoring, Intraoperative | 2 | 2016 | 957 | 0.390 |
Why?
|
Prognosis | 20 | 2023 | 29063 | 0.380 |
Why?
|
Necrosis | 3 | 2023 | 1643 | 0.370 |
Why?
|
Neurilemmoma | 3 | 2021 | 547 | 0.360 |
Why?
|
Preoperative Care | 3 | 2019 | 2250 | 0.350 |
Why?
|
Retrospective Studies | 36 | 2024 | 77449 | 0.350 |
Why?
|
Isocitrate Dehydrogenase | 7 | 2023 | 871 | 0.340 |
Why?
|
Facial Nerve | 3 | 2023 | 271 | 0.340 |
Why?
|
Tumor Burden | 6 | 2020 | 1915 | 0.340 |
Why?
|
Patient Readmission | 2 | 2020 | 3114 | 0.340 |
Why?
|
Insurance Coverage | 1 | 2020 | 1901 | 0.330 |
Why?
|
Skull Base | 4 | 2022 | 306 | 0.330 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3507 | 0.330 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 1018 | 0.320 |
Why?
|
Teratoma | 2 | 2015 | 395 | 0.310 |
Why?
|
Insurance, Health | 1 | 2020 | 2494 | 0.310 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5221 | 0.300 |
Why?
|
Combined Modality Therapy | 11 | 2023 | 8642 | 0.290 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2024 | 449 | 0.290 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2020 | 90 | 0.290 |
Why?
|
MELAS Syndrome | 1 | 2006 | 50 | 0.280 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2006 | 2 | 0.280 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.280 |
Why?
|
Adenoma, Oxyphilic | 2 | 2018 | 143 | 0.270 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2006 | 56 | 0.270 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13695 | 0.270 |
Why?
|
Astrocytoma | 3 | 2023 | 790 | 0.270 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2214 | 0.260 |
Why?
|
Male | 63 | 2023 | 350118 | 0.260 |
Why?
|
Immunotherapy | 5 | 2023 | 4445 | 0.250 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1832 | 0.240 |
Why?
|
Rhabdoid Tumor | 2 | 2017 | 212 | 0.240 |
Why?
|
Brain Abscess | 2 | 2015 | 118 | 0.240 |
Why?
|
Sella Turcica | 2 | 2015 | 119 | 0.240 |
Why?
|
Neuroendoscopy | 2 | 2016 | 105 | 0.240 |
Why?
|
Genomics | 8 | 2024 | 5720 | 0.240 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2645 | 0.240 |
Why?
|
DNA Mutational Analysis | 9 | 2017 | 4186 | 0.240 |
Why?
|
Hospitalization | 1 | 2023 | 10262 | 0.230 |
Why?
|
Telomerase | 2 | 2021 | 730 | 0.230 |
Why?
|
Epigenesis, Genetic | 2 | 2016 | 3647 | 0.230 |
Why?
|
Neuronavigation | 3 | 2021 | 167 | 0.230 |
Why?
|
Ganglia, Spinal | 1 | 2006 | 519 | 0.230 |
Why?
|
Internship and Residency | 1 | 2023 | 5788 | 0.230 |
Why?
|
Female | 57 | 2023 | 380194 | 0.220 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2305 | 0.220 |
Why?
|
Adult | 46 | 2024 | 214055 | 0.220 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2021 | 2043 | 0.220 |
Why?
|
Pharmacology | 1 | 2003 | 103 | 0.220 |
Why?
|
Dura Mater | 2 | 2024 | 291 | 0.210 |
Why?
|
Tissue Adhesives | 1 | 2024 | 179 | 0.210 |
Why?
|
Middle Aged | 48 | 2021 | 213383 | 0.210 |
Why?
|
Frozen Sections | 1 | 2002 | 155 | 0.210 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2002 | 428 | 0.210 |
Why?
|
Brain | 10 | 2023 | 26385 | 0.200 |
Why?
|
Pituitary Gland | 2 | 2015 | 665 | 0.200 |
Why?
|
Neoplasm Seeding | 2 | 2019 | 87 | 0.200 |
Why?
|
PTEN Phosphohydrolase | 4 | 2021 | 1142 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13102 | 0.190 |
Why?
|
Gene Dosage | 4 | 2017 | 1252 | 0.180 |
Why?
|
Comparative Genomic Hybridization | 6 | 2017 | 496 | 0.180 |
Why?
|
Neurofibromin 1 | 1 | 2021 | 196 | 0.180 |
Why?
|
Cerebellopontine Angle | 2 | 2021 | 55 | 0.180 |
Why?
|
GATA2 Transcription Factor | 1 | 2020 | 161 | 0.180 |
Why?
|
Pneumocephalus | 1 | 2020 | 46 | 0.180 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 327 | 0.170 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 916 | 0.170 |
Why?
|
Biology | 1 | 2022 | 294 | 0.170 |
Why?
|
Laminectomy | 2 | 2018 | 234 | 0.170 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2005 | 501 | 0.170 |
Why?
|
Facial Paralysis | 1 | 2023 | 338 | 0.170 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 72 | 0.170 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 194 | 0.170 |
Why?
|
Multilingualism | 1 | 2020 | 87 | 0.170 |
Why?
|
Cranial Sinuses | 1 | 2019 | 66 | 0.170 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.170 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3586 | 0.160 |
Why?
|
Postoperative Complications | 10 | 2023 | 15295 | 0.160 |
Why?
|
Chromosome Aberrations | 2 | 2016 | 1813 | 0.160 |
Why?
|
Salvage Therapy | 3 | 2019 | 1275 | 0.160 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2727 | 0.160 |
Why?
|
Hydrogels | 1 | 2024 | 724 | 0.160 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2021 | 175 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.160 |
Why?
|
Collateral Circulation | 1 | 2019 | 287 | 0.160 |
Why?
|
Phlebography | 2 | 2019 | 333 | 0.160 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 743 | 0.160 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 498 | 0.160 |
Why?
|
Interneurons | 1 | 2002 | 577 | 0.160 |
Why?
|
Aged | 30 | 2020 | 163280 | 0.150 |
Why?
|
Decompression, Surgical | 3 | 2018 | 594 | 0.150 |
Why?
|
Syringomyelia | 1 | 2018 | 64 | 0.150 |
Why?
|
Genome, Human | 4 | 2020 | 4420 | 0.150 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 895 | 0.150 |
Why?
|
Endoscopy | 3 | 2016 | 1785 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 2 | 2018 | 2849 | 0.150 |
Why?
|
Prospective Studies | 6 | 2023 | 53288 | 0.150 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.150 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 144 | 0.140 |
Why?
|
Cell Lineage | 2 | 2017 | 2504 | 0.140 |
Why?
|
Brevican | 2 | 2014 | 4 | 0.140 |
Why?
|
Cell Separation | 1 | 2002 | 1751 | 0.140 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1061 | 0.140 |
Why?
|
Nerve Tissue Proteins | 3 | 2007 | 4462 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 160 | 0.140 |
Why?
|
Neurofibromatoses | 1 | 2020 | 299 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2021 | 2948 | 0.140 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1513 | 0.140 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2016 | 19 | 0.140 |
Why?
|
Treatment Outcome | 15 | 2023 | 63114 | 0.140 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 45 | 0.140 |
Why?
|
World Health Organization | 1 | 2022 | 1318 | 0.140 |
Why?
|
Sphenoid Sinus | 1 | 2016 | 99 | 0.140 |
Why?
|
Arnold-Chiari Malformation | 1 | 2018 | 154 | 0.140 |
Why?
|
Ear Neoplasms | 1 | 2016 | 117 | 0.140 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
Neural Tube Defects | 1 | 2018 | 256 | 0.130 |
Why?
|
Young Adult | 18 | 2024 | 56430 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2018 | 736 | 0.130 |
Why?
|
Ganglioglioma | 1 | 2015 | 42 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 199 | 0.130 |
Why?
|
Endocrine Surgical Procedures | 1 | 2015 | 33 | 0.130 |
Why?
|
Psychosurgery | 1 | 2015 | 87 | 0.130 |
Why?
|
Pinealoma | 1 | 2015 | 54 | 0.130 |
Why?
|
INDEL Mutation | 1 | 2016 | 279 | 0.130 |
Why?
|
Molecular Chaperones | 1 | 2020 | 742 | 0.130 |
Why?
|
Hyponatremia | 1 | 2018 | 298 | 0.130 |
Why?
|
Odontoid Process | 1 | 2015 | 47 | 0.130 |
Why?
|
Chordoma | 1 | 2018 | 359 | 0.130 |
Why?
|
Infratentorial Neoplasms | 1 | 2015 | 94 | 0.130 |
Why?
|
DNA Methylation | 3 | 2023 | 4286 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3597 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2017 | 1758 | 0.120 |
Why?
|
Rhizopus | 1 | 2014 | 21 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1917 | 0.120 |
Why?
|
Famous Persons | 1 | 2015 | 108 | 0.120 |
Why?
|
Pituitary Diseases | 1 | 2015 | 141 | 0.120 |
Why?
|
Baseball | 1 | 2015 | 90 | 0.120 |
Why?
|
Vestibule, Labyrinth | 1 | 2016 | 235 | 0.120 |
Why?
|
Endopeptidases | 1 | 2018 | 772 | 0.120 |
Why?
|
Skull Neoplasms | 1 | 2015 | 173 | 0.120 |
Why?
|
Head Protective Devices | 1 | 2015 | 114 | 0.120 |
Why?
|
Medicine | 1 | 2003 | 946 | 0.120 |
Why?
|
Melanoma | 3 | 2022 | 5510 | 0.120 |
Why?
|
Liability, Legal | 1 | 2015 | 213 | 0.120 |
Why?
|
Transcription Factors | 5 | 2024 | 12208 | 0.120 |
Why?
|
Semantics | 1 | 2017 | 584 | 0.120 |
Why?
|
Epidural Abscess | 1 | 2015 | 84 | 0.120 |
Why?
|
Epidural Space | 1 | 2015 | 124 | 0.120 |
Why?
|
Telomere | 1 | 2020 | 910 | 0.120 |
Why?
|
Basal Ganglia Diseases | 1 | 2014 | 149 | 0.120 |
Why?
|
Meningitis, Bacterial | 1 | 2016 | 218 | 0.120 |
Why?
|
Diskectomy | 1 | 2015 | 206 | 0.120 |
Why?
|
Angiography, Digital Subtraction | 1 | 2015 | 341 | 0.120 |
Why?
|
Medulla Oblongata | 1 | 2015 | 243 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 9438 | 0.110 |
Why?
|
Military Personnel | 1 | 2022 | 1133 | 0.110 |
Why?
|
Mucormycosis | 1 | 2014 | 97 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 403 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2019 | 8949 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 949 | 0.110 |
Why?
|
Functional Laterality | 1 | 2020 | 2290 | 0.110 |
Why?
|
Oligodendroglioma | 1 | 2014 | 279 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2021 | 1826 | 0.110 |
Why?
|
Neoplasms | 2 | 2019 | 21683 | 0.110 |
Why?
|
Morbidity | 1 | 2018 | 1769 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1239 | 0.110 |
Why?
|
Radiation Injuries | 1 | 2020 | 1180 | 0.110 |
Why?
|
beta Catenin | 1 | 2018 | 1059 | 0.110 |
Why?
|
Ependymoma | 1 | 2016 | 334 | 0.110 |
Why?
|
Microsurgery | 2 | 2015 | 796 | 0.110 |
Why?
|
Aged, 80 and over | 13 | 2020 | 57776 | 0.110 |
Why?
|
Scalp | 1 | 2015 | 380 | 0.100 |
Why?
|
Disease Progression | 8 | 2019 | 13284 | 0.100 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39050 | 0.100 |
Why?
|
Social Class | 1 | 2021 | 1999 | 0.100 |
Why?
|
Nuclear Proteins | 4 | 2024 | 5853 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1248 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2017 | 13033 | 0.100 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1525 | 0.100 |
Why?
|
Oncogenes | 1 | 2017 | 1265 | 0.100 |
Why?
|
Cohort Studies | 8 | 2022 | 40561 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3508 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2016 | 639 | 0.090 |
Why?
|
Postoperative Period | 3 | 2021 | 1842 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 16689 | 0.090 |
Why?
|
Language | 1 | 2020 | 1471 | 0.090 |
Why?
|
Patient Discharge | 1 | 2023 | 3313 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 572 | 0.090 |
Why?
|
Curriculum | 1 | 2023 | 3605 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1676 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 2031 | 0.090 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2016 | 643 | 0.090 |
Why?
|
History, 20th Century | 4 | 2022 | 2740 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 760 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
SEER Program | 3 | 2022 | 1508 | 0.090 |
Why?
|
Neurofibromin 2 | 2 | 2023 | 267 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2376 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2018 | 2564 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2019 | 3327 | 0.080 |
Why?
|
Animals | 14 | 2024 | 168757 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.080 |
Why?
|
Algorithms | 3 | 2019 | 13881 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1563 | 0.080 |
Why?
|
Adolescent | 14 | 2023 | 85781 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1940 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3310 | 0.080 |
Why?
|
Survival Rate | 6 | 2019 | 12788 | 0.080 |
Why?
|
Clinical Competence | 1 | 2023 | 4687 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 990 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5708 | 0.080 |
Why?
|
Spine | 1 | 2015 | 1144 | 0.080 |
Why?
|
Child, Preschool | 5 | 2023 | 41006 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2736 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7913 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12261 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4851 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2017 | 2728 | 0.070 |
Why?
|
United States | 8 | 2022 | 69872 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2020 | 4803 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7729 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1376 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2925 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.070 |
Why?
|
Health Care Reform | 1 | 2015 | 1261 | 0.070 |
Why?
|
Macrophages | 1 | 2020 | 5655 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25043 | 0.070 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2007 | 243 | 0.070 |
Why?
|
Preoperative Period | 2 | 2018 | 549 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9648 | 0.070 |
Why?
|
Arachnoid Cysts | 1 | 2006 | 59 | 0.070 |
Why?
|
Hemianopsia | 1 | 2006 | 122 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2942 | 0.060 |
Why?
|
Remission Induction | 2 | 2021 | 2386 | 0.060 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2006 | 194 | 0.060 |
Why?
|
DNA Helicases | 2 | 2024 | 859 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6669 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5442 | 0.060 |
Why?
|
Brain Concussion | 1 | 2015 | 1320 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11524 | 0.060 |
Why?
|
Ascites | 1 | 2006 | 344 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2291 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7659 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2006 | 546 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2019 | 1770 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7799 | 0.060 |
Why?
|
Equipment Failure | 1 | 2006 | 578 | 0.060 |
Why?
|
Ultrasonography | 1 | 2016 | 5985 | 0.060 |
Why?
|
Brain Injuries | 1 | 2015 | 2025 | 0.060 |
Why?
|
Korean War | 1 | 2022 | 9 | 0.060 |
Why?
|
History, 19th Century | 2 | 2015 | 720 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2400 | 0.050 |
Why?
|
Carbocyanines | 1 | 2002 | 174 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 4043 | 0.050 |
Why?
|
Rhodamines | 1 | 2002 | 183 | 0.050 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2002 | 170 | 0.050 |
Why?
|
Atrophy | 1 | 2006 | 1583 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19905 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15076 | 0.050 |
Why?
|
Postoperative Care | 2 | 2019 | 1486 | 0.050 |
Why?
|
Vestibulocochlear Nerve | 1 | 2021 | 116 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3444 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 503 | 0.050 |
Why?
|
Seizures | 2 | 2024 | 2859 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3557 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9274 | 0.050 |
Why?
|
Hydrazines | 1 | 2002 | 226 | 0.050 |
Why?
|
Computer Systems | 1 | 2002 | 483 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2016 | 973 | 0.050 |
Why?
|
Calibration | 1 | 2023 | 816 | 0.050 |
Why?
|
Subdural Space | 1 | 2020 | 32 | 0.050 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 61 | 0.050 |
Why?
|
Child | 8 | 2023 | 77709 | 0.050 |
Why?
|
Reoperation | 3 | 2018 | 4201 | 0.050 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.050 |
Why?
|
Huntington Disease | 1 | 2007 | 1124 | 0.050 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2019 | 12 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 458 | 0.040 |
Why?
|
Lateral Sinus Thrombosis | 1 | 2019 | 8 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14722 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2022 | 579 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11366 | 0.040 |
Why?
|
Reference Standards | 1 | 2023 | 1025 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6770 | 0.040 |
Why?
|
Unemployment | 1 | 2021 | 214 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3712 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 326 | 0.040 |
Why?
|
Genetic Markers | 2 | 2015 | 2634 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 648 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2429 | 0.040 |
Why?
|
Geography | 1 | 2021 | 669 | 0.040 |
Why?
|
Syndrome | 1 | 2005 | 3251 | 0.040 |
Why?
|
Lasers | 1 | 2002 | 952 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2018 | 141 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 474 | 0.040 |
Why?
|
Head | 1 | 2023 | 880 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2503 | 0.040 |
Why?
|
Specimen Handling | 1 | 2002 | 694 | 0.040 |
Why?
|
Isoenzymes | 1 | 2002 | 1726 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 635 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 802 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4479 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23403 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 367 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10252 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
Face | 1 | 2023 | 994 | 0.040 |
Why?
|
Mice | 6 | 2022 | 81183 | 0.040 |
Why?
|
Brain Infarction | 1 | 2019 | 299 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2019 | 226 | 0.040 |
Why?
|
Automation | 1 | 2019 | 584 | 0.040 |
Why?
|
Hypophysectomy | 1 | 2016 | 113 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 426 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1143 | 0.040 |
Why?
|
Central Nervous System | 1 | 2024 | 1357 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 658 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2002 | 1221 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3760 | 0.030 |
Why?
|
Limit of Detection | 1 | 2017 | 265 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2085 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16365 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 627 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1266 | 0.030 |
Why?
|
Cell Tracking | 1 | 2017 | 145 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6600 | 0.030 |
Why?
|
Cranial Nerve Injuries | 1 | 2015 | 25 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5686 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 625 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1880 | 0.030 |
Why?
|
Verbal Behavior | 1 | 2017 | 339 | 0.030 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 520 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2021 | 853 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1337 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 72290 | 0.030 |
Why?
|
Rats | 3 | 2014 | 24260 | 0.030 |
Why?
|
Sphenoid Bone | 1 | 2016 | 172 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1276 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17446 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2737 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 315 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1038 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 911 | 0.030 |
Why?
|
Pineal Gland | 1 | 2015 | 166 | 0.030 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2015 | 55 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 744 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6756 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2019 | 4042 | 0.030 |
Why?
|
Pons | 1 | 2015 | 245 | 0.030 |
Why?
|
Cell Survival | 2 | 2014 | 5882 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5917 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 769 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1692 | 0.030 |
Why?
|
Gene Fusion | 1 | 2016 | 371 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2618 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 301 | 0.030 |
Why?
|
Steroids | 1 | 2018 | 930 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3588 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2540 | 0.030 |
Why?
|
Brain Stem Neoplasms | 1 | 2015 | 204 | 0.030 |
Why?
|
Wakefulness | 1 | 2020 | 1245 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2593 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1162 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3462 | 0.030 |
Why?
|
Homicide | 1 | 2015 | 287 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2015 | 395 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 921 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1442 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2015 | 930 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2018 | 10481 | 0.030 |
Why?
|
Income | 1 | 2021 | 1913 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1654 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1878 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2005 | 5021 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 890 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3689 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8301 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2020 | 2258 | 0.020 |
Why?
|
Hearing | 1 | 2015 | 482 | 0.020 |
Why?
|
Nose | 1 | 2015 | 509 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1072 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2716 | 0.020 |
Why?
|
Infant | 3 | 2018 | 35136 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20129 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 12951 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1504 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2015 | 1401 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2934 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3002 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1142 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1590 | 0.020 |
Why?
|
Visual Fields | 1 | 2016 | 1047 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12959 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1300 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1850 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 855 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 563 | 0.020 |
Why?
|
Poverty | 1 | 2021 | 2660 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2624 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1788 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1538 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2437 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2012 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2109 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 40075 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6538 | 0.020 |
Why?
|
Cerebellum | 1 | 2015 | 1488 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7181 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2015 | 1670 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7785 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2174 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3479 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4599 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1741 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6314 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2400 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2007 | 642 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5217 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 458 | 0.020 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2005 | 136 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6309 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2007 | 449 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3505 | 0.020 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2006 | 189 | 0.020 |
Why?
|
Ventriculostomy | 1 | 2006 | 136 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3521 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5867 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3086 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2007 | 2327 | 0.010 |
Why?
|
Genomic Instability | 1 | 2007 | 695 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9313 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2647 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21827 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8324 | 0.010 |
Why?
|
Glycosylation | 1 | 2005 | 1126 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5172 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2005 | 588 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1184 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1730 | 0.010 |
Why?
|
Heart Atria | 1 | 2006 | 1357 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4034 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.010 |
Why?
|
Visual Cortex | 1 | 2007 | 1149 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3475 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 25625 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9727 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11483 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12797 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3748 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9734 | 0.010 |
Why?
|
Neurons | 1 | 2007 | 9338 | 0.000 |
Why?
|